The reductions come at a time of significant growth overall for Lilly. and soon after the announcement of plans to build new ...

Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants ...

Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, part of a doubling of its investment in manufacturing.

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

Three of the sites will make active pharmaceutical ingredients, the foundational materials of medicines, while the fourth will make injectable products, the Indianapolis-based drug giant said ...

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

The new manufacturing sites are expected to create create 3,000 pharmaceutical jobs and nearly 10,000 construction positions during the buildout.

Eli Lilly wants the most optimal locations to host its new manufacturing facilities in the U.S.—and it’s open to pitche | Eli ...

Eli Lilly said Wednesday it will invest $27 billion ... the threat of drug import duties from the Trump administration. The Indianapolis-based company said three of the planned facilities will ...

Presiding over the upward trajectory of Eli Lilly over the last eight years is paying off nicely for CEO David Ricks. | ...

INDIANAPOLIS — Eli Lilly and Company is announcing a massive new set of investments in U.S. manufacturing. The company plans to more than double its investments since 2020, bringing the total to more ...